Molecular imaging in oncology

Egesta Lopci; Stefano Fanti

doi:10.1007/978-3-642-10853-2-13

Molecular imaging in oncology

Egesta Lopci, Stefano Fanti

Istituto Clinico Humanitas

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

The major application for PET imaging in clinical practice is represented by cancer imaging and ¹⁸F-FDG is the most widely employed positron emitter compound. However, some diseases cannot be properly evaluated with this tracer and thus there is the necessity to develop more specific compounds. The last decades were a continuous factory for new radiopharmaceuticals leading to an endless list of PET tracers; however, just some of them guard diagnostic relevance in routine medical practice. This chapter describes a selected list of non-FDG PET tracers, basing on their introduction into and impact on clinical practice.

Original language	English
Title of host publication	Recent Results in Cancer Research
Pages	371-400
Number of pages	30
Volume	187
DOIs	https://doi.org/10.1007/978-3-642-10853-2-13
Publication status	Published - 2013

Publication series

Name	Recent Results in Cancer Research
Volume	187
ISSN (Print)	00800015

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1007/978-3-642-10853-2-13

Fingerprint Dive into the research topics of 'Molecular imaging in oncology'. Together they form a unique fingerprint.

Cite this

@inbook{adf9c6b8366242a589616c9e62bf80de,

title = "Molecular imaging in oncology",

abstract = "The major application for PET imaging in clinical practice is represented by cancer imaging and 18F-FDG is the most widely employed positron emitter compound. However, some diseases cannot be properly evaluated with this tracer and thus there is the necessity to develop more specific compounds. The last decades were a continuous factory for new radiopharmaceuticals leading to an endless list of PET tracers; however, just some of them guard diagnostic relevance in routine medical practice. This chapter describes a selected list of non-FDG PET tracers, basing on their introduction into and impact on clinical practice.",

author = "Egesta Lopci and Stefano Fanti",

year = "2013",

doi = "10.1007/978-3-642-10853-2-13",

language = "English",

isbn = "9783642108525",

volume = "187",

series = "Recent Results in Cancer Research",

pages = "371--400",

booktitle = "Recent Results in Cancer Research",

}

TY - CHAP

T1 - Molecular imaging in oncology

AU - Lopci, Egesta

AU - Fanti, Stefano

PY - 2013

Y1 - 2013

N2 - The major application for PET imaging in clinical practice is represented by cancer imaging and 18F-FDG is the most widely employed positron emitter compound. However, some diseases cannot be properly evaluated with this tracer and thus there is the necessity to develop more specific compounds. The last decades were a continuous factory for new radiopharmaceuticals leading to an endless list of PET tracers; however, just some of them guard diagnostic relevance in routine medical practice. This chapter describes a selected list of non-FDG PET tracers, basing on their introduction into and impact on clinical practice.

AB - The major application for PET imaging in clinical practice is represented by cancer imaging and 18F-FDG is the most widely employed positron emitter compound. However, some diseases cannot be properly evaluated with this tracer and thus there is the necessity to develop more specific compounds. The last decades were a continuous factory for new radiopharmaceuticals leading to an endless list of PET tracers; however, just some of them guard diagnostic relevance in routine medical practice. This chapter describes a selected list of non-FDG PET tracers, basing on their introduction into and impact on clinical practice.

UR - http://www.scopus.com/inward/record.url?scp=84871830741&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84871830741&partnerID=8YFLogxK

U2 - 10.1007/978-3-642-10853-2-13

DO - 10.1007/978-3-642-10853-2-13

M3 - Chapter

C2 - 23179889

AN - SCOPUS:84871830741

SN - 9783642108525

VL - 187

T3 - Recent Results in Cancer Research

SP - 371

EP - 400

BT - Recent Results in Cancer Research

ER -